Search results

Order by most recent / most popular / relevance

Results: 1-3 of 3

Large-scale joint drug venture and MOUs bind North Carolina and China’s Zhejian

Shook Hardy & Bacon LLP
-
China, USA
-
August 4 2011

North Carolina’s Hamner Institutes for Health Sciences and Ascletis Inc., a U.S.-China pharmaceutical company, have signed a memorandum of understanding (MOU) to support the first large-scale joint venture in biotechnology between North Carolina and China’s Zhejian Province

Medicinova and Zhejiang Medicine announce joint venture in China

Shook Hardy & Bacon LLP
-
China, USA
-
March 10 2011

California-based biopharmaceutical company MediciNova Inc. and Zhejiang Medicine Co., a Chinese pharmaceutical manufacturer, have announced a joint venture to develop and commercialize MediciNova’s MN-221 in China

Chinese billionaire backs U.S.China biopharma venture

Shook Hardy & Bacon LLP
-
China, USA
-
April 21 2011

Chinese real-estate billionaire Qi Jinzing has reportedly begun investing in the biotech sector despite its potential financial risks

Current Search

Author - Madeleine McDonough
Author - Thomas T. Moga
Author - Patrick Henderson
Firm Name - Shook Hardy & Bacon LLP
Jurisdiction - USA
Jurisdiction - China
Workarea - Healthcare

Search results

Large-scale joint drug venture and MOUs bind North Carolina and China’s Zhejian

Medicinova and Zhejiang Medicine announce joint venture in China

Chinese billionaire backs U.S.China biopharma venture

Current Search

Suggested Facets